<DOC>
	<DOCNO>NCT01152606</DOCNO>
	<brief_summary>This single cohort observational safety study . All patient treat monitor accord local clinical practice . No additional procedures/patient visit comparison usual clinical practice plan study . Data collect centre 's medical record 5 year death .</brief_summary>
	<brief_title>A Study Cardiac Safety Patients With HER2 Positive Early Breast Cancer Treated With Herceptin</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Trastuzumab</mesh_term>
	<criteria>All patient consider candidate receive Herceptin indication Patients Herceptin contraindicate</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>